Company Wuhan General Group (China), Inc. Other OTC
Equities
WUHN
US9825691051
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Cannabinoids and Psilocybin Medical Research
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -57.40% |
Sales per region
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -57.40% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeff Robinson
FOU | Founder | - | 18/07/88 |
Willem Jonker
DFI | Director of Finance/CFO | - | 04/10/20 |
Riyad Domingo
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/21 |
Chief Tech/Sci/R&D Officer | - | 21/01/19 | |
Warren Kansley
SAM | Sales & Marketing | - | - |
Robert Simbowe
PRN | Corporate Officer/Principal | - | 23/05/21 |
Rameez Adair
PRN | Corporate Officer/Principal | - | 02/06/20 |
Corporate Officer/Principal | - | 02/06/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | 21/01/19 | |
Jeff Robinson
FOU | Founder | - | 18/07/88 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 6,354,078 | 0 | 0 | 76.65 % |
Stock B | 1 | 55,149,662 | 42,271,310 ( 76.65 %) | 0 | |
Stock C | 0 | 6,241,453 | 0 | 0 |
Company contact information
Wuhan General Group (China), Inc.
Unit 01, Mason's Press 7 Ravenscraig Road
7925, Cape Town
+
http://www.m2bio.coSector
1st Jan change | Capi. | |
---|---|---|
+23.77% | 44.96B | |
+0.35% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.82% | 26.08B | |
-21.16% | 19.03B | |
+6.38% | 12.75B | |
+29.23% | 12.06B | |
-3.33% | 11.75B |